Position in GRAL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$5,202,174
+$1,615,582 QoQ
Shares Held
76,200
+9.8% QoQ
Ownership
0.171%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#49
of 374 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Swiss National Bank holds $1,850,525,303 across 27 Diagnostics & Research names. GRAL ranks #20 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,048,120 | $525,485,443 | |
| 2 | DHR |
Danaher Corp /De/
|
1,796,508 | $342,198,843 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
224,020 | $117,933,088 | |
| 4 | A |
Agilent Technologies, Inc.
|
797,200 | $105,892,076 | |
| 5 | WAT |
Waters Corp /De/
|
277,334 | $104,011,343 | |
| 6 | NTRA |
Natera, Inc.
|
379,800 | $103,096,710 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
478,680 | $92,490,549 | |
| 8 | ILMN |
Illumina, Inc.
|
420,400 | $73,918,932 |
All Filings in GRAL
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,202,174 | 76,200 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $3,586,592 | 69,400 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,188,157 | 72,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,506,409 | 59,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,121,194 | 60,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,496,644 | 58,600 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $972,825 | 54,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $749,920 | 54,500 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $860,720 | 56,000 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||